Topic

Cerezyme (imiglucerase)

A collection of 26 issues

If Cerezyme (Imiglucerase) Isn't Approved by Blue Cross Blue Shield in Virginia: Formulary Alternatives & Exception Paths

Answer Box If Blue Cross Blue Shield Virginia denies Cerezyme (imiglucerase) for Gaucher disease, you have three main paths: request a formulary exception with medical necessity documentation, consider FDA-approved alternatives like VPRIV or Elelyso if covered, or pursue Virginia's external review process through the State Corporation Commission. Start
6 min read

Renewing Cerezyme (Imiglucerase) Approval with Blue Cross Blue Shield in Illinois: Complete Guide to Annual Reauthorization

Answer Box: Renewing Your Cerezyme Coverage in Illinois Blue Cross Blue Shield of Illinois (BCBSIL) requires annual reauthorization for Cerezyme (imiglucerase). Start the renewal process 30-45 days before your current authorization expires. You'll need updated clinical documentation showing continued medical necessity, current lab values, and treatment response data.
5 min read